Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: West Pharmaceutical Services, Inc.

Market Cap 22.86B 19.72B 18.13B 17.07B 32.07B 2,157B 32.34B 215B 83.66B 1,059B 85.8B 83.97B 3,663B P/E 2026 *
38.4x
P/E 2027 * 33.7x
Enterprise Value 22.12B 19.08B 17.54B 16.51B 31.03B 2,087B 31.29B 208B 80.94B 1,025B 83.02B 81.24B 3,544B EV / Sales 2026 *
6.64x
EV / Sales 2027 * 6.17x
Free-Float
93.54%
Yield 2026 *
0.28%
Yield 2027 * 0.3%
1 month 253.33
Extreme 253.329
253.33
Current year 253.33
Extreme 253.329
253.33
1 year 253.33
Extreme 253.329
253.33
3 years 253.33
Extreme 253.329
253.33
5 years 253.33
Extreme 253.329
253.33
10 years 253.33
Extreme 253.329
253.33
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 23.28B
-2.34%-0.75%-33.10%-16.67% 158B
-3.91%-2.63%-9.32%-12.35% 104B
+2.53%+10.41%+65.18%+62.25% 56.43B
-1.55%-1.48%-5.49%+51.41% 54.76B
-2.45%-4.18%-16.67%-45.25% 40B
-1.81%-0.33% - - 31.36B
-2.64%-4.73%-12.95%-45.25% 28.23B
-0.33%-1.13%-14.90%-4.83% 20.41B
-3.44%-4.18%-15.89%-6.65% 20.13B
Average -1.59%-1.47%-5.39%-2.17% 57.06B
Weighted average by Cap. -1.91%-0.95%-9.28%-1.89%

Financials

2026 *2027 *
Net sales 3.33B 2.87B 2.64B 2.49B 4.67B 314B 4.71B 31.31B 12.19B 154B 12.5B 12.24B 534B 3.54B 3.05B 2.81B 2.64B 4.96B 334B 5B 33.25B 12.95B 164B 13.28B 12.99B 567B
Net income 605M 522M 480M 451M 848M 57.07B 855M 5.68B 2.21B 28.01B 2.27B 2.22B 96.89B 686M 591M 544M 512M 962M 64.7B 970M 6.44B 2.51B 31.75B 2.57B 2.52B 110B
Net Debt -741M -640M -588M -554M -1.04B -69.97B -1.05B -6.97B -2.71B -34.34B -2.78B -2.72B -119B -1.03B -885M -814M -766M -1.44B -96.87B -1.45B -9.65B -3.76B -47.54B -3.85B -3.77B -164B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
323.59USD
Average target price
358.79USD
Spread / Average Target
+10.88%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!